Earnings Feed
Start Free
Esperion Therapeutics, Inc.·4

Mar 15, 4:32 PM ET

Halladay Benjamin 4

4 · Esperion Therapeutics, Inc. · Filed Mar 15, 2024

Insider Transaction Report

Form 4
Period: 2024-03-14
Esperion Therapeutics, Inc.ESPR
Halladay Benjamin
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2024-03-14+170,000→ 243,936 total
  • Award

    Stock Option (right to buy)

    2024-03-14+200,000→ 200,000 total
    Exercise: $2.05Exp: 2034-03-14→ Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]Such award will vest over a four (4) year period in equal quarterly installments, the first of which will be June 15, 2024.

Documents

2 files